Pay in 4 interest-free payments of $6.83 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
SLU-PP-332 SLU-PP-332 is a novel small molecule and a potent pan-agonist of the estrogen-related receptors (ERR, ERR, and ERR), which are key regulators of energy metabolism and mitochondrial function
Contact the clinic to schedule a consultation and get clear, individualized guidance
Journal of Clinical Epidemiology, 47 (9), 10211026
7 Clinical studies on breast cancer using natural supplements In a study, subgroups of breast cancer were evaluated those without mammary abnormalities in the extra tumour epithelium glandular, those with non-proliferative breast cancer (n=127) and finally, 155 NPFCs and 185 PFCs were compared with their respective controls (n=903 vs 127 normal) (240)
Studied in: Comparative hGH-fragment research, adipocyte and lipid-pathway studies in cell culture, receptor-interaction analysis, and structure-function comparisons against full-length growth hormone in controlled laboratory models
US$ 28.38
US$ 22.23
US$ 21.34
